0001493152-17-003301.txt : 20170331 0001493152-17-003301.hdr.sgml : 20170331 20170331195847 ACCESSION NUMBER: 0001493152-17-003301 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170331 DATE AS OF CHANGE: 20170331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nascimento Egidio CENTRAL INDEX KEY: 0001615616 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37769 FILM NUMBER: 17731968 MAIL ADDRESS: STREET 1: C/O VBI VACCINES INC. STREET 2: 222 THIRD STREET, STE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 3 1 form3.xml X0206 3 2016-12-31 0 0000764195 VBI Vaccines Inc/BC VBIV 0001615616 Nascimento Egidio C/O VBI VACCINES INC 222 THIRD STREET, STE 2241 CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Shares, no par value per share 2968 D Option (Right to Buy Common Shares) 2.94 2018-03-18 Common Shares 4671 D Option (Right to Buy Common Shares) 4.87 2019-01-21 Common Shares 13519 D Option (Right to Buy Common Shares) 2.94 2022-03-29 Common Shares 5357 D Option (Right to Buy Common Shares) 2.94 2022-04-02 Common Shares 5357 D Option (Right to Buy Common Shares) 4.51 2024-07-25 Common Shares 153106 D Option (Right to Buy Common Shares) 4.74 2025-07-30 Common Shares 78031 D Option (Right to Buy Common Shares) 3.90 2026-06-22 Common Shares 75000 D The option is fully vested. The option vests 1/48th of the total shares monthly following the grant date of July 25, 2014, subject to continued service through each vesting date. The option vests 1/48th of the total shares monthly following the grant date of July 30, 2015, subject to continued service through each vesting date. The option vests 1/48th of the total shares monthly following the grant date of June 22, 2016, subject to continued service through each vesting date. Exercise price is in Canadian dollars, United States dollars equivalent is shown using the closing foreign exchange rate on December 31, 2016. The original exercise price of USD $3.65 was changed by the Issuer's board of directors to USD $3.90 to reflect the correct exercise price as calculated in accordance with the Issuer's Incentive Plan. /s/ Egidio Nascimento 2017-03-31